Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery

Placenta

Volumn 32, Issue SUPPL. 1, 2011, Pages

  Sammar, M ^a,b   Nisemblat, S ^a,b   Fleischfarb, Z ^c   Golan, A ^c   Sadan, O ^c,d   Meiri, H ^a   Huppertz, B ^e   Gonen, R ^f  

^a Diagnostic Technologies Ltd   (Israel)

^b ORT BRAUDE COLLEGE   (Israel)

^c Wolfson Medical Centre   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

HELLP; PP13; Preeclampsia; Preterm delivery

Indexed keywords

MESSENGER RNA; PLACENTA PROTEIN; PLACENTA PROTEIN 13; UNCLASSIFIED DRUG;

ADULT; AMNION FLUID; ARTICLE; BODY FLUID; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; FETUS BLOOD; HELLP SYNDROME; HUMAN; HUMAN TISSUE; MATERNAL SERUM; PARAMETER; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD;

ADULT; BODY FLUIDS; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; FEMALE; FETAL BLOOD; GALECTINS; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH; RNA, MESSENGER;

EID: 79251498930     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.09.006     Document Type: Article

References (34)

1. H. Bohn, W. Krause, and W. Winckler Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17) Oncodev Biol Med 4 1983 343 350
2. N.G. Than, B. Sumegi, G.N. Than, Z. Berente, and H. Bohn Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP-13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein Placenta 20 1999 703 710
3. B. Visegrady, N.G. Than, F. Kiler, B. Sumegi, G.N. Than, and H. Bohn Homology modeling and molecular dynamics studies of human placental tissue protein 13 (galectin-13) Protein Eng 14 2001 875 880
4. O. Burger, E. Pick, J. Zwickel, H. Klayman, H. Meiri, and R. Slotky Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies Placenta 25 2004 608 622
5. N.G. Than, E. Pick, S. Bellyei, A. Szigeti, O. Burger, and Z. Berente Functional analyses of placental protein 13/galectin-13 Eur J Biochem 271 2004 1065 1078
6. B. Huppertz, M. Sammar, I. Chefetz, P. Neumaier-Wagner, C. Bartz, and H. Meiri Longitudinal determination of serum placental protein 13 during development of preeclampsia Fetal Diagn Ther 24 2008 230 236
7. R. Gonen, R. Shahar, Y. Grimpel, I. Chefetz, M. Sammar, and H. Meiri Placental protein 13 an early marker for pre-eclampsia: a prospective longitudinal study Br J Obstet Gynaecol 115 2008 1465 1472
8. K.H. Nicolaides, R. Bindra, M.T. Ozhan, I. Chefetz, M. Sammar, and H. Meiri A novel approach to first trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound Ultrasound Obstet Gynecol 27 2006 13 17
9. K. Spencer, N.J. Cowans, I. Chefetz, J. Tal, and H. Meiri First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia Ultrasound Obstet Gynecol 29 2007 128 134
10. K. Spencer, N.J. Cowans, I. Chefetz, J. Tal, I. Kunreich, and H. Meiri Second-trimester uterine artery Doppler pulsatility index and maternal serum pp13 as markers of pre-eclampsia first trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction Prenat Diagn 27 2007 258 263
11. I. Chefetz, I. Kuhnreich, M. Sammar, Y. Tal, Y. Giber, and H. Meiri First trimester placental protein 13 screening for preeclampsia intrauterine growth restriction Am J Obstet Gynecol 197 2007 35.e1-7
12. N.J. Cowans, K. Spencer, and H. Meiri First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes Prenat Diagn 28 2008 121 125
13. R. Romero, J.P. Kusanovic, N.G. Than, O. Erez, F. Gotsch, and J. Espinoza First trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction Am J Obstet Gynecol 199 2008 122e1-11
14. A. Khalil, N.J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk Prenat Diagn 2009 doi: 10.1002/pd
15. R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K.N. Nicolaides Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia Prenat Diagn 2009 doi: 10.1002/pd
16. E.J. Wortelboer, M.P. Koster, H.S. Cuckle, P.H. Stoutenbeek, P.C. Schielen, and G.H. Visser First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia BJOG 117 2010 1384 1389
17. A. Stamatopoulou, N.J. Cowans, E. Matwejew, C. von Kaisenberg, and K. Spencer Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes Hypertens Pregnancy 2010 Aug 11 [Epub ahead of print]
18. N.G. Than, R. Romero, R. Hillerman, V. Cozzi, G. Nie, and B. Huppertz Prediction of pre-eclampsia - a workshop report Placenta 29 Suppl. 1 2008 83 85
19. D.A. Davey, and I. MacGillivray The classification and definition of the hypertensive disorders of pregnancy Am J Obstet Gynecol 158 1988 892 898
20. M.A. Brown, M.D. Lindheimer, M. de Swiet, A. Van Assche, and J.M. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 [IX-XIV]
21. B.M. Sibai Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count Obstet Gynecol 103 2004 981 991
22. G. Than, R. Romero, M. Goodman, A. Weckle, J. Xing, and Z. Dong A primate subfamily of galectins expressed at the maternal-fetal interface that promote cell death Proc Natl Acad Sci U S A 24 2009 9731 9736
23. A. Boronkai, S. Bellyei, A. Azigeti, E. Pozsgai, Z. Bognar, and B. Sumegi Potentiation of pactlitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and Erk1/2 activation in U-937 human macrophages Eur J Cell Biol 88 2009 753 763
24. A. Sekizawa, Y. Purwosunu, S. Yoshimura, M. Nakamura, H. Shimizu, and T. Okai PP13 mRNA expression in trophoblasts from preeclamptic placentas Reprod Sci 16 2009 408 413
25. H. Shimizu, A. Sekizawa, Y. Purwosunu, M. Nakamura, A. Farina, and N. Rizzo PP13 mRNA in the cellular component of maternal blood as a marker for preeclampsia Prenat Diagn 29 2009 1231 1236
26. G. Than, O. Abdul-Rahman, R. Magenheim, B. Nagy, T. Fule, and B. Hargitai Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome Virchows Arch 453 2008 387 400
27. D. Goswami, D.S. Tannetta, L.A. Magee, A. Fuchisawa, C.W. Redman, and I.L. Sargent Excess syncytiotrophoblast microparticles shedding are a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction Placenta 27 2006 56 61
28. S.E. Maynard, J.W. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
29. Y. Zhou, M. McMaster, K. Woo, M. Janatpour, J. Perry, and T. Karpanen Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome Am J Pathol 160 2002 1405 1423
30. J. Guibourdenche, J.L. Frendo, G. Pidoux, G. Bertin, D. Luton, and F. Muller Expression of pregnancy-associated plasma protein-a (PAPP-A) during human villous trophoblast differentiation in vitro Placenta 24 2003 532 539
31. E.M.L. Smet, A. Visser, A.T.J.I. Go, J.M.G. Van Vugt, and C.B.M. Qudejans Novel biomarkers in preeclampsia Clin Chim Acta 364 2006 22 32
32. M. Koster, E. Wortelboer, H. Cuckle, P. Stoutenbeek, H. Visser, and P. Schielen Placental protein 13 as a first trimester screening marker for aneuploidy Prenat Diagn 29 2009 1237 1241
33. D. Declacour, and R. Koch A Jacob The role of galectins in protein trafficking Traffic 10 2009 1405 1413
34. X. Lee, J.C. Keith Jr., N. Stumm, I. Moutsatsos, J.M. McCoy, and C.P. Crum Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia Placenta 22 2001 808 812